Treatment of the neurologic manifestations of Wilson's disease.
Scheinberg
I H
IH
Sternlieb
I
I
D004112:Dimercaprol / Q000627:therapeutic use; D006527:Hepatolenticular Degeneration / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D008982:Molybdenum / Q000627:therapeutic use*; D009422:Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy*; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use
D004112:Dimercaprol; D008982:Molybdenum; C020809:tetrathiomolybdate; D010396:Penicillamine